STRATA Skin Sciences Achieves Milestone with Over 100 TheraClear®X Devices Installed

STRATA Skin Sciences

HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced a significant milestone in its operations, having surpassed 100 installations of its TheraClear®X acne treatment devices by the end of the first quarter of 2024. This achievement underscores the company’s growing influence in the dermatology sector and its commitment to advancing acne treatment through innovative technology.

STRATA is strategically focusing on increasing TheraClear®X placements within clinics that already use its XTRAC® system, leveraging existing relationships to introduce this new acne therapy. The company’s partnership network includes private equity-backed dermatology groups such as the California Skin Institute and Aqua Dermatology, as well as other strategic accounts like Pennsylvania Dermatology Partners, which boasts 35 clinics.

A notable aspect of STRATA’s expansion strategy involves collaborations with 48 private equity-backed clinical dermatology groups, encompassing a total of 2,482 clinic locations. To date, STRATA has deployed 386 XTRAC® devices and 62 TheraClear®X devices across these locations, indicating a robust growth trajectory in the dermatological device market.

Dr. Dolev Rafaeli, CEO of STRATA Skin Sciences, highlighted the significance of TheraClear®X in the treatment of acne, stating, “TheraClear®X addresses many of the limitations of existing acne therapies, and its effectiveness is often visible after just a few treatments.” The device’s unique photo pneumatic technology, which combines vacuum and pulsed broadband light, offers a multifaceted approach to treating active acne lesions. This not only enhances treatment outcomes but also provides dermatologists with a reimbursable option that can improve practice economics.

The adoption of TheraClear®X marks a pivotal development in acne treatment, offering hope to millions suffering from this prevalent skin condition. By delivering effective and visible results after a few sessions, TheraClear®X positions itself as a valuable tool in dermatologists’ arsenals. With plans to further expand its domestic installation base, STRATA Skin Sciences is set to continue playing a critical role in evolving dermatological care, potentially reshaping the landscape of acne treatment.

READ:  INOVIO Reports Promising Long-Term Data for INO-3107 in Treating RRP

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.